1. Home
  2. EOS vs AMPH Comparison

EOS vs AMPH Comparison

Compare EOS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOS
  • AMPH
  • Stock Information
  • Founded
  • EOS 2005
  • AMPH 1996
  • Country
  • EOS United States
  • AMPH United States
  • Employees
  • EOS N/A
  • AMPH N/A
  • Industry
  • EOS Trusts Except Educational Religious and Charitable
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • EOS Finance
  • AMPH Health Care
  • Exchange
  • EOS Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • EOS 1.3B
  • AMPH 1.2B
  • IPO Year
  • EOS N/A
  • AMPH 2014
  • Fundamental
  • Price
  • EOS $23.65
  • AMPH $23.77
  • Analyst Decision
  • EOS
  • AMPH Buy
  • Analyst Count
  • EOS 0
  • AMPH 6
  • Target Price
  • EOS N/A
  • AMPH $35.50
  • AVG Volume (30 Days)
  • EOS 84.1K
  • AMPH 379.2K
  • Earning Date
  • EOS 01-01-0001
  • AMPH 11-05-2025
  • Dividend Yield
  • EOS 6.80%
  • AMPH N/A
  • EPS Growth
  • EOS N/A
  • AMPH N/A
  • EPS
  • EOS N/A
  • AMPH 2.68
  • Revenue
  • EOS N/A
  • AMPH $722,679,000.00
  • Revenue This Year
  • EOS N/A
  • AMPH $1.37
  • Revenue Next Year
  • EOS N/A
  • AMPH $6.93
  • P/E Ratio
  • EOS N/A
  • AMPH $8.88
  • Revenue Growth
  • EOS N/A
  • AMPH 1.37
  • 52 Week Low
  • EOS $15.62
  • AMPH $20.39
  • 52 Week High
  • EOS $20.63
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • EOS 44.21
  • AMPH 33.34
  • Support Level
  • EOS $23.35
  • AMPH $22.94
  • Resistance Level
  • EOS $24.35
  • AMPH $24.20
  • Average True Range (ATR)
  • EOS 0.34
  • AMPH 0.84
  • MACD
  • EOS -0.04
  • AMPH -0.20
  • Stochastic Oscillator
  • EOS 30.01
  • AMPH 18.65

About EOS Eaton Vance Enhance Equity Income Fund II

Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: